| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.106.11.1036/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036 |
| Version | 20210220 |
| Status | active |
| Date | 2021-02-20T01:02:00-05:00 |
| Name | SubstanceUseDisorderTreatment |
| Title | Substance Use Disorder Treatment |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for encounters for substance use disorder treatment.),(Data Element Scope: This value set may use a model element related to Intervention.),(Inclusion Criteria: Includes concepts that represent an encounter for substance use disorder treatment.),(Exclusion Criteria: No exclusions.) |
| ValueSet | |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.12.1005  | Substance Use Disorder Treatment |
No resources found
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.464.1003.106.11.1036",
"meta" : {
"versionId" : "5",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "NCQA PHEMUR Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-02-14"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2021-02-20"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.464.1003.106.11.1036"
}
],
"version" : "20210220",
"name" : "SubstanceUseDisorderTreatment",
"title" : "Substance Use Disorder Treatment",
"status" : "active",
"experimental" : false,
"date" : "2021-02-20T01:02:00-05:00",
"publisher" : "NCQA PHEMUR",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for encounters for substance use disorder treatment.),(Data Element Scope: This value set may use a model element related to Intervention.),(Inclusion Criteria: Includes concepts that represent an encounter for substance use disorder treatment.),(Exclusion Criteria: No exclusions.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"concept" : [
{
"code" : "G2067",
"display" : "Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2068",
"display" : "Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2069",
"display" : "Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2070",
"display" : "Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2071",
"display" : "Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2072",
"display" : "Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2073",
"display" : "Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2074",
"display" : "Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2075",
"display" : "Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"code" : "G2076",
"display" : "Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient's short-term goals and the tasks the patient must perform to complete the short-term goals; the patient's requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
},
{
"code" : "G2077",
"display" : "Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
},
{
"code" : "G2080",
"display" : "Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
},
{
"code" : "G2086",
"display" : "Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month"
},
{
"code" : "G2087",
"display" : "Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month"
},
{
"code" : "H0020",
"display" : "Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"
},
{
"code" : "H0033",
"display" : "Oral medication administration, direct observation"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:6239964e-96c4-46ea-81b3-6709bb7cbdfb",
"timestamp" : "2024-12-10T10:31:16-05:00",
"total" : 16,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2067",
"display" : "Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2068",
"display" : "Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2069",
"display" : "Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2070",
"display" : "Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2071",
"display" : "Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2072",
"display" : "Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2073",
"display" : "Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2074",
"display" : "Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2075",
"display" : "Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2076",
"display" : "Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient's short-term goals and the tasks the patient must perform to complete the short-term goals; the patient's requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2077",
"display" : "Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2080",
"display" : "Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2086",
"display" : "Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "G2087",
"display" : "Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "H0020",
"display" : "Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"version" : "2024",
"code" : "H0033",
"display" : "Oral medication administration, direct observation"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.